Early epigenomic and transcriptional changes reveal Elk-1 transcription factor as a therapeutic target in Huntington’s disease.

Ferah Yildirim, Christopher W. Ng, Vincent Kappes, Tobias Ehrenberger, Siobhan K. Rigby, Victoria Stivanello, Theresa A. Gipson, Anthony R. Soltis, Peter Vanhoutte, Jocelyne Caboche, David E. Housman, Ernest Fraenkel